Literature DB >> 19345373

Effects of bone marrow and hepatocyte transplantation on liver injury.

Biao Zhang1, Mitsuhiro Inagaki, Bojian Jiang, Masaaki Miyakoshi, Jun Arikura, Katsuhiro Ogawa, Shinichi Kasai.   

Abstract

BACKGROUND: The therapeutic effects of bone marrow and hepatocyte transplantation were investigated regarding the treatment of retrorsine-partial hepatectomy-induced liver injury.
METHODS: Analbuminemic F344alb rats were given two doses of retrorsine 2 wk apart, followed 4 wk later by transplantation with F344 rat bone marrow cells or hepatocytes immediately after a two-thirds hepatectomy. The survival rate, liver regeneration rate, liver functions, albumin-positive hepatocytes, and normal albumin gene sequences in the liver and serum albumin levels were investigated in the recipients.
RESULTS: Although 65% retrorsine/partial hepatectomy-treated F344alb died between 1 and 11 d after the partial hepatectomy, only 27.5% of the animals died following bone marrow transplantation, and 50% with hepatocyte transplantation. Both bone marrow and hepatocyte transplantation ameliorated acute liver injury after a partial hepatectomy. Bone marrow transplantation yielded a very small increase in the number of albumin-positive hepatocytes in the liver, while hepatocyte transplantation resulted in massive replacement of the liver tissues by the donor hepatocytes associated with an elevation of serum albumin after an extended time.
CONCLUSIONS: Both bone marrow and hepatocyte transplantation could prevent acute hepatic injury, conceivably due to a paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345373     DOI: 10.1016/j.jss.2008.12.013

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.

Authors:  Mervat El-Ansary; Iman Abdel-Aziz; Sherif Mogawer; Samah Abdel-Hamid; Olfat Hammam; Salwa Teaema; Marwa Wahdan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  A novel cell-free strategy for promoting mouse liver regeneration: utilization of a conditioned medium from adipose-derived stem cells.

Authors:  Sang Kuon Lee; Sang Chul Lee; Say-June Kim
Journal:  Hepatol Int       Date:  2014-12-25       Impact factor: 6.047

3.  Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action.

Authors:  Wen-Ting Bin; Li-Mei Ma; Qing Xu; Xiao-Lin Shi
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

4.  Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure.

Authors:  Cheng-Maw Ho; Ya-Hui Chen; Chin-Sung Chien; Shu-Li Ho; Hui-Ling Chen; Rey-Heng Hu; Po-Huang Lee
Journal:  Korean J Transplant       Date:  2020-06-30

5.  Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation.

Authors:  Peng Gong; Yingxin Wang; Yulin Wang; Shi Jin; Haifeng Luo; Jing Zhang; Haidong Bao; Zhongyu Wang
Journal:  Tumour Biol       Date:  2013-04-13

Review 6.  Stem cells in liver regeneration and their potential clinical applications.

Authors:  Ioannis Drosos; George Kolios
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

Review 7.  Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.

Authors:  Xiang-Rui Ma; Ya-Ling Tang; Ming Xuan; Zheng Chang; Xiao-Yi Wang; Xin-Hua Liang
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

8.  Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cell Res Ther       Date:  2015-04-14       Impact factor: 6.832

9.  Paracrine Effects of Bone Marrow Mononuclear Cells in Survival and Cytokine Expression after 90% Partial Hepatectomy.

Authors:  Carlos Oscar Kieling; Carolina Uribe-Cruz; Mónica Luján López; Alessandro Bersch Osvaldt; Themis Reverbel da Silveira; Ursula Matte
Journal:  Stem Cells Int       Date:  2017-02-23       Impact factor: 5.443

10.  Umbilical cord blood stem cells transplantation as an adjunctive treatment strategy for liver cirrhosis in Chinese population: a meta-analysis of effectiveness and safety.

Authors:  Huimin Tao; Yafeng Li; Tingting Wang; Changhui Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-02-26       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.